YV

Yogesh Vishnuprasad Joshi

Active Director Director DIN 11029234
DIN 11029234 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Yogesh Vishnuprasad Joshi

Data last updated:

Yogesh Vishnuprasad Joshi is a Director at Manvir Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11029234
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Mar 20252025Active

Board colleagues of Yogesh Vishnuprasad Joshi

NameDINCompanyDesignation
Ekta Yogesh Joshi11029233Manvir Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Manvir Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Yogesh Vishnuprasad Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Vishnuprasad Joshi

Yogesh Vishnuprasad Joshi currently holds 1 directorship: Manvir Pharmaceuticals Private Limited (Director, since 30 Mar 2025).

Yogesh Vishnuprasad Joshi was first appointed on 30 Mar 2025 as Director at Manvir Pharmaceuticals Private Limited.

The current boards of Yogesh Vishnuprasad Joshi's companies include Ekta Yogesh Joshi (Manvir Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available